Molecular glue degraders: Lilly, AbbVie sign billion-dollar deals; BMS leads with three late-stage drugs

Data Compilation
#PharmaFlow

Pipeline Prospector Feb 2025: Bain buys Mitsubishi Tanabe for US$ 3.4 bn; Japan’s Ono gets FDA nod for rare joint tumor drug

Stock Recap
#PipelineProspector

Pantoprazole Sodium

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

143 API Suppliers, 58 USDMF, 51 CEP/COS, 40 EU WC, 18 KDMF, 31 NDC API, 86 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

3 Drugs in Development

3 Drugs in Development

INTERMEDIATES

31 Intermediate Suppliers

31 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

1189 FDF Dossiers, 66 FDA Orange Book, 682 Europe, 40 Canada, 131 Australia, 71 South Africa, 199 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

POWDER;INTRAVENOUS - EQ 40MG BASE/VIAL, TABLET, DELAYED RELEASE;ORAL - EQ 20MG BASE, TABLET, DELAYED RELEASE;ORAL - EQ 40MG BASE, INJECTABLE;INTRAVENOUS - EQ 40MG BASE/VIAL

RELATED EXCIPIENT COMPANIES

1 Minakem, 12 Evonik, 1 Rochem International Inc, 21 SPI Pharma, 7 DKSH, 5 Faran Shimi Pharmaceutical, 7 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 6 Gangwal Healthcare, 8 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 1 Pramukh Pharmachem, 1 Zeal MediPharma, 1 ACG Worldwide, 6 Actylis, 2 Aeon Procare, 3 Alcedo Pharmachem, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Avesta Pharma, 35 BASF, 2 Clariant, 16 Corel Pharma Chem, 6 DFE Pharma, 3 Doshion Polyscience, 2 Finar, 13 Gangwal Chemicals, 15 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 39 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 14 Microlex e.U, 1 Nanjing Bold Chemical, 1 NEWEDGE Overseas, 2 Nomisma Healthcare, 4 Novo Excipients, 5 Pharmatrans-Sanaq, 5 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 21 Roquette, 14 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 2 The Dow Chemical Company, 2 Ulanqab Kema New Material, 3 Valens Pharmachem, 3 Vasa Pharmachem, 1 Vertellus

EXCIPIENTS BY APPLICATIONS

87 Fillers, Diluents & Binders, 82 Coating Systems & Additives, 45 Controlled & Modified Release, 41 Direct Compression, 38 Disintegrants & Superdisintegrants, 36 Solubilizers, 33 Taste Masking, 33 Thickeners and Stabilizers, 29 Granulation, 26 Film Formers & Plasticizers, 21 Chewable & Orodispersible Aids, 21 Lubricants & Glidants, 20 Topical, 19 Parenteral, 17 Co-Processed Excipients, 9 Emulsifying Agents, 6 Surfactant & Foaming Agents, 6 API Stability Enhancers, 6 Rheology Modifiers, 5 Empty Capsules, 5 Coloring Agents, 4 Vegetarian Capsules

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 61 News #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 640 Regulatory FDF Prices, 9 Annual Reports

MARKET PLACE

67 APIs, 55 FDF Dossiers

PATENTS & EXCLUSIVITIES

5 US Patents, 1 US Exclusivities, 22 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 3 USP, 21 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Holder	DMF No.	Subject	Submission Date	Status	Type	GDUFA DMF Review	GDUFA Review Date	GDUFA Payment Date
28/03/2025	IOL Chemicals and Pharmaceuticals	India	IOL CHEMICALS AND PHARMACEUTICALS LTD	36375	PANTOPRAZOLE SODIUM USP	2021-12-28	Active	II	N/A
28/03/2025	Metrochem API Private Limited	India	METROCHEM API PRIVATE LTD	35577	PANTOPRAZOLE SODIUM	2021-03-29	Active	II	N/A

Pantoprazole Sodium

Pantoprazole Sodium

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

143 API Suppliers

58 USDMF

51 CEP/COS

40 EU WC

18 KDMF

31 NDC API

86 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

3 Drugs in Development

INTERMEDIATES

31 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

1189 FDF Dossiers

66 FDA Orange Book

682 Europe

40 Canada

131 Australia

71 South Africa

199 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

POWDER;INTRAVENOUS - EQ 40MG BASE/VIAL

TABLET, DELAYED RELEASE;ORAL - EQ 20MG BASE

TABLET, DELAYED RELEASE;ORAL - EQ 40MG BASE

INJECTABLE;INTRAVENOUS - EQ 40MG BASE/VIAL

RELATED EXCIPIENT COMPANIES

1 Minakem

12 Evonik

1 Rochem International Inc

21 SPI Pharma

7 DKSH

5 Faran Shimi Pharmaceutical

7 Boai NKY Pharmaceuticals Ltd

1 Chynops Pharma

6 Gangwal Healthcare

8 Nanjing Well Pharmaceutical

2 Pfanstiehl

1 Pramukh Pharmachem

1 Zeal MediPharma

1 ACG Worldwide

6 Actylis

2 Aeon Procare

3 Alcedo Pharmachem

8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 Avesta Pharma

35 BASF

2 Clariant

16 Corel Pharma Chem

6 DFE Pharma

3 Doshion Polyscience

2 Finar

13 Gangwal Chemicals

15 Ideal Cures Pvt Ltd

4 Ingredion Pharma Solutions

39 Kerry

3 Kima Chemical

6 Lonza Capsugel

14 Microlex e.U

1 Nanjing Bold Chemical

1 NEWEDGE Overseas

2 Nomisma Healthcare

4 Novo Excipients

5 Pharmatrans-Sanaq

5 Pluviaendo

3 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

21 Roquette

14 Seppic

5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

11 Sigachi Industries

2 The Dow Chemical Company